African Americans who inherit one sickle cell gene and one normal gene —  a condition known as sickle cell trait…
Articles by Catarina Silva, MSc
Global Blood Therapeutics (GBT)Â intends to improve access to high-quality healthcare for people with sickle cell disease (SCD) in…
The blood-separation device Spectra Optia, which has the ability to remove abnormal red blood cells from sickle cell patients,…
McKesson Plasma and Biologics LLC will distribute Endari, a therapy indicated to reduce the acute complications of…
Hoffmann-La Roche has sold the worldwide rights to its discontinued heart disease drug, inclacumab, to Global Blood Therapeutics (GBT) for…
Siklos (hydroxyurea 100 mg tablets) — indicated for the treatment of pediatric patients, ages 2 and older, with…
The Sickle Cell Foundation of Georgia (SCFG) has partnered with Biotech Research Laboratories and the Phoenix Tears Foundation…
Loss of an important part of the antioxidant cell defense system decreases production of hemoglobin in the blood and worsens…
Researchers used a gene editing tool to insert mutations into blood cells to increase their production of fetal hemoglobin, which…
Despite an increased risk of invasive pneumococcal disease (IPD) in children with sickle cell anemia (SCA), preventive treatment (prophylaxis) rates remain…